The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

The MHRA has approved depemokimab as an add-on treatment for severe asthma and chronic rhinosinusitis with nasal polyps.

For many, these price reductions may represent a critical step in improving access to essential medications, especially as ...

Medicare beneficiaries will see major pricing shifts as federal negotiations reshape how costly prescription drugs are paid ...

As with any medicine, the MHRA will keep the safety and effectiveness of depemokimab under close review. The Medicines and Healthcare products ...

Povorcitinib is a selective oral small-molecule JAK1 inhibitor, with compound and use patents in certain countries/regions in the Territory. Currently, povorcitinib is in Phase 3 clinical trials for ...

STUART, Fla., Dec. 16, 2025 /PRNewswire/ -- The United States is entering a period of significant disruption in healthcare coverage, according to health policy observers, with millions of Americans ...

Coming up in the back half of December, the FDA will issue a verdict on Vanda Pharmaceuticals’ gastroparesis drug tradipitant ...

Shamim earns Tk75,000 a month working at a private company in Dhaka. Yet even that income is no longer enough to keep his ...

This winter, medical experts guide you through the latest diagnostic standards, the non-deficiency causes of fatigue, and the practical steps you can take ...

"Mike & Molly" star Billy Gardell lost 170 pounds through bariatric surgery after reaching 370 pounds and developing diabetes ...

Hey, so you’ve probably heard about the recent health news surrounding a certain comedian's dramatic weight change, right? It ...